Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GEN-001 |
Trade Name | |
Synonyms | GEN 001|GEN001 |
Drug Descriptions |
GEN-001 is a microbiome therapy derived from a single strain of bacteria isolated from healthy donors that, upon delivery, may produce metabolites that increase expression of interleukins (IL7 and IL15) and activate dendritic cells and macrophages, potentially resulting in the induction of cytotoxic immune response against tumor cells (NCI Drug Dictionary). |
DrugClasses | Microbiome 7 |
CAS Registry Number | NA |
NCIT ID | C171422 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + GEN-001 | Avelumab GEN-001 | 0 | 1 |
GEN-001 | GEN-001 | 0 | 0 |